Towards the synthesis of histone deacetylase inhibitors based on the depsipeptide FK228
Towards the synthesis of histone deacetylase inhibitors based on the depsipeptide FK228
Histones are proteins that are used as a scaffold for DNA to wrap around and on these proteins are lysines. Histone Deacetylases (HDACs) are metalloenzymes that remove acetyl groups from lysines on histones and thus cause genetic material to wrap tighter which can stop transcription. If the genes that can regulate tumour activity are affected by this method, then these are rendered inactive. In cancer patients, it can be seen that the amount of HDACs are higher than normal then in a normal person and this has created the need to understand these and find products that can inhibit these. The search for inhibitors have led to such products as SAHA, FK228 and spiruchostatins (both of the latter are depsipeptides with disulfide bridges) and by researching depsipeptides such as FK228, more understanding can be made in how these compounds work. Depsipeptides such as FK228 consist of from three components, a zinc binding thiol, which is the active site, a 'cap', which is the macrocycle and a linker that connects the two. This research shows how attempts at modifying key components, such as the linker length and saturation and the 'cap' structure of the depsipeptides have been made.
University of Southampton
Mo, Hon Kit
09b05ae7-d63e-4a4a-ac31-dddadb139fbe
2008
Mo, Hon Kit
09b05ae7-d63e-4a4a-ac31-dddadb139fbe
Mo, Hon Kit
(2008)
Towards the synthesis of histone deacetylase inhibitors based on the depsipeptide FK228.
University of Southampton, Doctoral Thesis.
Record type:
Thesis
(Doctoral)
Abstract
Histones are proteins that are used as a scaffold for DNA to wrap around and on these proteins are lysines. Histone Deacetylases (HDACs) are metalloenzymes that remove acetyl groups from lysines on histones and thus cause genetic material to wrap tighter which can stop transcription. If the genes that can regulate tumour activity are affected by this method, then these are rendered inactive. In cancer patients, it can be seen that the amount of HDACs are higher than normal then in a normal person and this has created the need to understand these and find products that can inhibit these. The search for inhibitors have led to such products as SAHA, FK228 and spiruchostatins (both of the latter are depsipeptides with disulfide bridges) and by researching depsipeptides such as FK228, more understanding can be made in how these compounds work. Depsipeptides such as FK228 consist of from three components, a zinc binding thiol, which is the active site, a 'cap', which is the macrocycle and a linker that connects the two. This research shows how attempts at modifying key components, such as the linker length and saturation and the 'cap' structure of the depsipeptides have been made.
Text
1219630.pdf
- Version of Record
More information
Published date: 2008
Identifiers
Local EPrints ID: 466561
URI: http://eprints.soton.ac.uk/id/eprint/466561
PURE UUID: 294e1f2c-0a91-445f-8d90-b926763d889f
Catalogue record
Date deposited: 05 Jul 2022 05:47
Last modified: 16 Mar 2024 20:46
Export record
Contributors
Author:
Hon Kit Mo
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics